An ongoing commitment to groundbreaking research.
Building on our deep academic roots, InBio places a strong emphasis on sound scientific research. By engaging in active collaborations with both academia and industry over the past 25 years, InBio has developed an unblemished history of scientific integrity, subject-matter expertise, and a well-earned reputation for thought leadership. InBio’s 140+ scientific publications are testament to the focus on advancing technologies in asthma and allergy.
Thanks to this research focus, InBio is one of only a few commercial companies to receive a prestigious National Institute of Health (NIH) R01 grant. Grants from the NIH, as well as the European Union, government agencies and research foundations, support a range of research projects.
Read about some of InBio’s recent and notable efforts. Contact InBio to discuss any research needs.
Financial Conflict of Interest Policy
InBio has developed a Financial Conflict of Interest Policy (FCOI) in accordance with Federal and NIH requirements for Public Health Service funded research (42 CFR Part 50 Subpart F). This policy promotes objectivity in research and includes requirements for training of investigators, monitoring FCOI, reporting to NIH and ensuring compliance. If you have any questions about this policy, please contact Dr. Anna Pomés.
Want in? Subscribe to the InBio Newsletter stay up to date on all the latest innovations.